查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1529649

核磁共振波譜市場規模、佔有率、趨勢分析報告：2024-2030 年按類型、產品、最終用途、地區和細分市場預測

Nuclear Magnetic Resonance Spectroscopy Market Size, Share & Trends Analysis Report By Type (Low-field, High-field), By Products (Instruments, Consumables), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

核磁共振波譜市場成長與趨勢：

Grand View Research, Inc.的最新報告顯示，到2030年，全球核磁共振波譜市場規模預計將達到10.8億美元。

預計2024年至2030年該市場將以5.1%的複合年成長率擴張。由於對代謝體學特異性診斷的需求不斷成長，加上各領域的使用量增加，預計該市場將快速成長。布魯克為多組體學、組織 SpatialOMx、蛋白質組學、功能結構生物學、生物分子縮合、生物製藥和應用提供核磁共振 (NMR) 光譜解決方案。

核磁共振波譜市場預計將在 2021 年逐步成長，並在預測期內表現出類似的趨勢。學術和大學研究中心對設備的需求對收益貢獻很大。例如，2021 年 6 月，美國國家科學基金會宣布投資 4000 萬美元，用於開發喬治亞大學、康涅狄格大學醫學院和威斯康星大學麥迪遜分校國家磁共振設施之間的高級核磁共振網路 (NAN)。過。

其他決定因素，例如對學名藥的需求快速成長、醫療保健技術進步、政府舉措和核磁共振波譜行業的津貼也促進了市場的成長。在美國，政府資助的-S10儀器計劃已經建立，以協助購買設備，包括核磁共振波譜儀。目前有三個活躍的財政援助計劃，截止日期為 2023 年 6 月。這些計劃的金額從 25,000 美元到 2,000,000 美元不等。

COVID-19 的爆發預計將對該產品的需求產生積極影響。然而，供不應求和原物料價格上漲影響了參與企業的盈利。過去十年來，超導體中使用的關鍵原料（例如銅、鐵和金屬）的價格不斷上漲。

癌症診斷需求的不斷成長預計將在未來幾年顯著推動市場成長。正在使用核磁共振波譜研究帕金森氏症、癌症、感染疾病和精神疾病的診斷。例如，2022 年 1 月，牛津大學進行了研究，開發一種新的血液測試，可以利用 NMR代謝體學識別各種癌症。

另一方面，這是一個利基市場，參與企業有限。此外，核磁共振波譜被認為體積龐大且昂貴，400 MHz 的核磁共振波譜花費數十萬美元，高場磁鐵花費數百萬美元。此外，需要定期填充低溫流體的高場磁體，並且需要定期維護電子設備和探頭，這增加了成本。

核磁共振波譜市場報告亮點

  • 從產品來看，由於大學和研究中心對高場核磁共振波譜的需求不斷增加，設備領域在核磁共振波譜產業中佔據了壓倒性的佔有率。
  • 產品範圍的穩步擴大正在對市場產生重大影響。例如，固體核磁共振波譜 (SSNMR) 被認為是藥物表徵的分析工具，從而推動了市場成長。
  • 按類型分類，高場核磁共振波譜細分市場將在 2023 年佔據主導地位。
  • 按最終用途分類，2023 年學術領域佔據主要佔有率。許多大學已採用核磁共振分析來增強製藥和化學工業中化學品的鑑定。
  • 由於擁有大量大學以及政府為加強研究基礎設施提供的資金不斷增加，到 2023 年，北美將在全球市場中佔據主要佔有率。
  • 由於原料供應的增加以及製藥和生物技術行業生物醫學研究的增加，預計亞太地區未來將顯著成長。

目錄

第1章調查方法和範圍

第2章執行概述

第3章核磁共振波譜市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 核磁共振波譜市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 核磁共振波譜市場的主要相關人員

第4章核磁共振波譜市場：產品估算與趨勢分析

  • 全球核磁共振波譜市場：產品、儀表板
  • 全球核磁共振波譜市場：產品變異分析
  • 全球核磁共振波譜市場：依產品、按收益
  • 裝置
  • 消耗品

第5章核磁共振波譜市場：類型、估計和趨勢分析

  • 全球核磁共振波譜市場：類型儀表板
  • 全球核磁共振波譜市場：類型變異分析
  • 全球核磁共振波譜市場：按類型、按收益
  • 低場核磁共振波譜
  • 高場核磁共振波譜

第6章核磁共振波譜市場：最終應用、估計與趨勢分析

  • 全球核磁共振波譜市場：最終用途儀表板
  • 全球核磁共振波譜市場：最終用途變化分析
  • 全球核磁共振波譜市場：依最終用途、按收益
  • 學術的
  • 製藥和生物技術公司
  • 農業和食品
  • 化工
  • 其他

第7章核磁共振波譜市場：按類型、產品、應用和最終用途的區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 2023年主要企業市場佔有率分析
    • JEOL Ltd.
    • Thermo Fisher Scientific Inc.
    • Bruker
    • Magritek
    • Oxford Instruments
    • Nanalysis Corp.
    • Anasazi Instruments, Inc.
    • QOneTec
    • Advanced Magnetic Resonance Limited
Product Code: GVR-4-68039-963-1

Nuclear Magnetic Resonance Spectroscopy Market Growth & Trends:

The global nuclear magnetic resonance spectroscopy market size is expected to reach USD 1.08 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 5.1% from 2024 to 2030. The rising need for metabolomics-based diagnosis, coupled with increasing usage in various fields, is anticipated to surge the growth of the market. Bruker offers nuclear magnetic resonance (NMR) spectroscopy solutions for multi-omics, tissue SpatialOMx, proteomics, functional structural biology, biomolecular condensates, and biopharma and applied.

The market for NMR spectroscopy witnessed incremental growth in 2021 and is anticipated to showcase a similar trend in the forecast period. The instrument demand from academic and university research centers is a significant contributor to the revenue. For instance, in June 2021, National Science Foundation announced an investment of USD 40 million to develop the Network for Advanced NMR (NAN) between the University of Georgia, UConn School of Medicine, and UW-Madison's National Magnetic Resonance Facility at Madison.

Other determinants such as the rapidly expanding demand for generic medicine, technical improvements in healthcare, as well as government initiatives and grants in the nuclear magnetic resonance spectroscopy industry are also contributing to the market's growth. In the U.S., government-funded - S10 Instrumentation Programs have been formed to support the purchase of instruments, including NMR spectroscopy. There are three active funding programs with June 2023 as the deadline. These programs range from USD 25,000 to USD 2,000,000.

The COVID-19 pandemic is anticipated to positively impact the demand for the product. However, supply shortages and accelerated prices of raw materials impacted the profitability of the players. The prices of key raw materials such as copper, steel, and metallic, used for superconductors, have risen over the last decade.

The increasing demand for cancer diagnostics is expected to majorly drive market growth in the coming years. Diagnosis for Parkinson's disease, cancer, infectious diseases, and psychiatric disorders, has been investigated with the use of NMR spectroscopy. For instance, in January 2022, a study was conducted at the University of Oxford to develop a new blood test, through NMR metabolomics, that can identify a range of cancers.

On the other hand, this is a niche market with limited players. Additionally, NMR spectroscopy is considered to be bulky and expensive, as its cost ranges from around a few hundred thousand dollars for 400 MHz, to millions for higher field magnets. Additionally, the requirement of high-field magnets, filled with cryogenic fluids regularly, and routine maintenance of electronics and probes increases the cost.

Nuclear Magnetic Resonance Spectroscopy Market Report Highlights:

  • By product, the instruments segment held the dominant share of the NMR spectroscopy industry, owing to the increasing demand by universities and research centers for high-field NMR spectroscopy
  • The steadily increasing scope of the product has a significant impact on the market. For instance, solid-state NMR spectroscopy (SSNMR) is considered an analytical tool for drug characterization, hence propelling the market growth
  • By type, the high-field NMR spectroscopy segment dominated the market in 2023, since it offers better sensitivity to the researchers
  • By end-use, the academic segment held a larger share in 2023; numerous universities employ NMR analysis to enhance chemical identification in pharmaceutical and chemical industries
  • North America held a substantial share in the global market in 2023 due to the presence of a large number of universities and increasing funding support by the government to enhance research infrastructure
  • The Asia Pacific region is projected to grow considerably in the future, owing to the rising availability of raw materials and increasing biomedical research in the pharma and biotech industry

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Type
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product and type outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Nuclear Magnetic Resonance Spectroscopy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Development Of Generic Drugs / API
      • 3.2.1.2. Acceleration In Biomedical Research
      • 3.2.1.3. Increasing Metabolomics-Based Diagnosis
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Expensive Equipment And Maintenance At Low Sensitivity
      • 3.2.2.2. The Presence Of Interfering Substances Disrupts The Research
  • 3.3. Nuclear Magnetic Resonance Spectroscopy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Key Stakeholders in the NMR Spectroscopy Market

Chapter 4. Nuclear Magnetic Resonance Spectroscopy Market: Product Estimates & Trend Analysis

  • 4.1. Global Nuclear Magnetic Resonance Spectroscopy Market: Product Dashboard
  • 4.2. Global Nuclear Magnetic Resonance Spectroscopy Market: Product Movement Analysis
  • 4.3. Global Nuclear Magnetic Resonance Spectroscopy Market by Product, Revenue
  • 4.4. Instruments
    • 4.4.1. Instruments market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.5. Consumables
    • 4.5.1. Consumables market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Nuclear Magnetic Resonance Spectroscopy Market: Type Estimates & Trend Analysis

  • 5.1. Global Nuclear Magnetic Resonance Spectroscopy Market: Type Dashboard
  • 5.2. Global Nuclear Magnetic Resonance Spectroscopy Market: Type Movement Analysis
  • 5.3. Global Nuclear Magnetic Resonance Spectroscopy Market by Type, Revenue
  • 5.4. Low-field NMR Spectroscopy
    • 5.4.1. Low-field NMR spectroscopy market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.5. High-field NMR spectroscopy
    • 5.5.1. High-field NMR Spectroscopy market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Nuclear Magnetic Resonance Spectroscopy Market: End Use Estimates & Trend Analysis

  • 6.1. Global Nuclear Magnetic Resonance Spectroscopy Market: End Use Dashboard
  • 6.2. Global Nuclear Magnetic Resonance Spectroscopy Market: End Use Movement Analysis
  • 6.3. Global Nuclear Magnetic Resonance Spectroscopy Market by End Use, Revenue
  • 6.4. Academic
    • 6.4.1. Academic market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. Pharmaceutical and Biotech Companies
    • 6.5.1. Pharmaceutical and biotech companies market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Agriculture and Food
    • 6.6.1. Agriculture and food market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7. Chemical Industry
    • 6.7.1. Chemical industry market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Nuclear Magnetic Resonance Spectroscopy Market: Regional Estimates & Trend Analysis by Type, Tube Material, Application, and End-use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 - 2030
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.6. Denmark
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.4. South Korea
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.6. Singapore
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Singapore market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework/ reimbursement structure
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. JEOL Ltd.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Thermo Fisher Scientific Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Bruker
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Magritek
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Oxford Instruments
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Nanalysis Corp.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Anasazi Instruments, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. QOneTec
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Advanced Magnetic Resonance Limited
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 5 Global Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 6 Global Nuclear Magnetic Resonance Spectroscopy, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Nuclear Magnetic Resonance Spectroscopy, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 9 North America Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 10 North America Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 12 U.S. Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Canada Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 15 Canada Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 16 Canada Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Europe Nuclear Magnetic Resonance Spectroscopy, by Country, 2018 - 2030 (USD Million)
  • Table 18 Europe Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 19 Europe Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 20 Europe Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 21 Germany Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 22 Germany Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 23 Germany Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 24 UK Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 25 UK Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 26 UK Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 27 France Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 28 France Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 29 France Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 30 Italy Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 31 Italy Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 32 Italy Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Spain Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 34 Spain Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 35 Spain Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 36 Denmark Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 37 Denmark Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 38 Denmark Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 39 Sweden Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 40 Sweden Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 41 Sweden Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Norway Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 43 Norway Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 44 Norway Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Nuclear Magnetic Resonance Spectroscopy, by Country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 49 China Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 50 China Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 51 China Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 52 Japan Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 53 Japan Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 54 Japan Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 55 India Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 56 India Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 57 India Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 58 South Korea Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 59 South Korea Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 60 South Korea Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Australia Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 62 Australia Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 63 Australia Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 64 Singapore Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 65 Singapore Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 66 Singapore Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Thailand Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 68 Thailand Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 69 Thailand Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Nuclear Magnetic Resonance Spectroscopy, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 72 Latin America Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 73 Latin America Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 75 Brazil Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 76 Brazil Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 77 Mexico Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 78 Mexico Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 79 Mexico Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 80 Argentina Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 81 Argentina Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 82 Argentina Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Nuclear Magnetic Resonance Spectroscopy, by Country, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 85 Middle East & Africa Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 86 Middle East & Africa Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 87 South Africa Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 88 South Africa Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 89 South Africa Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 91 Saudi Arabia Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 93 UAE Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 94 UAE Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 95 UAE Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 97 Kuwait Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 98 Kuwait Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Nuclear Magnetic Resonance Spectroscopy Market Segmentation
  • Fig. 8 Market Snapshot, 2023
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Nuclear Magnetic Resonance Spectroscopy Market: Product Movement Analysis
  • Fig. 16 Global Nuclear Magnetic Resonance Spectroscopy Market, for Instruments, 2018 - 2030 (USD Million)
  • Fig. 17 Global Nuclear Magnetic Resonance Spectroscopy Market, for Consumables, 2018 - 2030 (USD Million)
  • Fig. 18 Global Nuclear Magnetic Resonance Spectroscopy Market: Type Movement Analysis
  • Fig. 19 Global Nuclear Magnetic Resonance Spectroscopy Market, for Low-field NMR Spectroscopy, 2018 - 2030 (USD Million)
  • Fig. 20 Global Nuclear Magnetic Resonance Spectroscopy Market, for High-field NMR Spectroscopy, 2018 - 2030 (USD Million)
  • Fig. 21 Global Nuclear Magnetic Resonance Spectroscopy Market: End-use Movement Analysis
  • Fig. 22 Global Nuclear Magnetic Resonance Spectroscopy Market, for Academic, 2018 - 2030 (USD Million)
  • Fig. 23 Global Nuclear Magnetic Resonance Spectroscopy Market, for Pharmaceutical and Biotech Companies, 2018 - 2030 (USD Million)
  • Fig. 24 Global Nuclear Magnetic Resonance Spectroscopy Market, for Agriculture and Food, 2018 - 2030 (USD Million)
  • Fig. 25 Global Nuclear Magnetic Resonance Spectroscopy Market, for Chemical Industry, 2018 - 2030 (USD Million)
  • Fig. 26 Global Nuclear Magnetic Resonance Spectroscopy Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 27 Regional Marketplace: Key Takeaways
  • Fig. 28 Regional Outlook, 2023 & 2030
  • Fig. 29 Global Nuclear Magnetic Resonance Spectroscopy Market: Region Movement Analysis
  • Fig. 30 North America Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 32 Canada Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 33 Europe Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 34 Germany Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 35 UK Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 36 France Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 37 Italy Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 38 Spain Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 39 Denmark Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 40 Sweden Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 41 Norway Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 43 Japan Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 44 China Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 45 India Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 46 Australia Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 47 South Korea Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 48 Singapore Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 52 Mexico Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 57 UAE Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)